EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation

Ling Li, Jannah Baker, Renee Quirk, Danielle Deidun, Maria Moran, Ahmed Abo Salem, Nanda Aryal, Bethany A Van Dort, Wu Yi Zheng, Andrew Hargreaves, Paula Doherty, Sarah N Hilmer und 3 weitere

Drug Safety · 2024-06 · 47 (6) · 557-569

DOI: 10.1007/s40264-024-01412-w ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Drug Safety, online erschienen am 13.03.2024. Verfasst von Ling Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Health and Human Sciences, Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie U…. Hauptthemen laut MEDLINE: Drug Interactions, Hospitalization. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council, Macquarie University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Drug-drug interactions (DDIs) have potential to cause patient harm, including lowering therapeutic efficacy. This study aimed to (i) determine the prevalence of potential DDIs (pDDIs); clinically relevant DDIs (cDDIs), that is, DDIs that could lead to patient harm, taking into account a patient's individual clinical profile, drug effects and severity of potential harmful outcome; and subsequent actual harm among hospitalized patients and (ii) examine the impact of transitioning from paper-based medication charts to electronic medication management (eMM) on DDIs and patient harms. METHODS: This was a secondary analysis of the control arm of a controlled pre-post study. Patients were randomly selected from three Australian hospitals. Retrospective chart review was conducted before and after the implementation of an eMM system, without accompanying clinical decision support alerts for DDIs. Harm was assessed by an expert panel. RESULTS: Of 1186 patient admissions, 70.1% (n = 831) experienced a pDDI, 42.6% (n = 505) a cDDI and 0.9% (n = 11) an actual harm in hospital. Of 15,860 pDDIs identified, 27.0% (n = 4285) were classified as cDDIs. The median number of pDDIs and cDDIs per 10 drugs were 6 [interquartile range (IQR) 2-13] and 0 (IQR 0-2), respectively. In cases where a cDDI was identified, both drugs were 44% less likely to be co-administered following eMM (adjusted odds ratio 0.56, 95% confidence interval 0.46-0.73). CONCLUSION: Although most patients experienced a pDDI during their hospital stay, less than one-third of pDDIs were clinically relevant. The low prevalence of harm identified raises questions about the value of incorporating DDI decision support into systems given the potential negative impacts of DDI alerts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug InteractionsHospitalizationHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAustraliaPrevalenceDrug-Related Side Effects and Adverse ReactionsAdultPatient HarmAged, 80 and overDecision Support Systems, ClinicalMedication Errors

Autor:innen und Institutionen

  • Faculty of Medicine, Health and Human Sciences, Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia. li…
  • Faculty of Medicine, Health and Human Sciences, Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia.
  • Biomedical Informatics and Digital Health, University of Sydney, Sydney, NSW, Australia.
  • Black Dog Institute, Sydney, NSW, Australia.
  • eHealth NSW, Sydney, NSW, Australia.
  • John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia.

Förderung

  • National Health and Medical Research Council
  • Macquarie University

Zitieren

APA

Li, L., Baker, J., Quirk, R., Deidun, D., Moran, M., Salem, A. A., Aryal, N., Van Dort, B. A., Zheng, W. Y., Hargreaves, A., Doherty, P., Hilmer, S. N., Day, R. O., Westbrook, J. I., & Baysari, M. T. (2024). Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation. Drug Safety, 47(6), 557-569. https://doi.org/10.1007/s40264-024-01412-w

Vancouver

Li L, Baker J, Quirk R, Deidun D, Moran M, Salem AA, et al. Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation. Drug Safety. 2024;47(6):557-569. doi:10.1007/s40264-024-01412-w

BibTeX
@article{Li2024,
  author = {Li, Ling and Baker, Jannah and Quirk, Renee and Deidun, Danielle and Moran, Maria and Salem, Ahmed Abo and Aryal, Nanda and Van Dort, Bethany A and Zheng, Wu Yi and Hargreaves, Andrew and Doherty, Paula and Hilmer, Sarah N and Day, Richard O and Westbrook, Johanna I and Baysari, Melissa T},
  title = {Drug–Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation},
  journal = {Drug Safety},
  year = {2024},
  volume = {47},
  number = {6},
  pages = {557--569},
  doi = {10.1007/s40264-024-01412-w}
}
Kostenlos starten →